Javar, Jonathan B.

HRN: 25-46-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/10/2024
07/17/2024
IV
500mg
Q8
Obstructive Jaundice
Waiting Final Action 
07/10/2024
CEFTRIAXONE 1G (VIAL)
07/10/2024
07/17/2024
IV
2g
Q24
Obstructive Jaundice
Waiting Final Action 
07/13/2024
CIPROFLOXACIN 500MG (TAB)
07/13/2024
07/19/2024
PO
500mg
Q12
OBSTRUCTIVE JAUNDICE SECONDARY TO CHOLEDOCHOLITHIASIS IN MODERATE CHOLANGITIS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: